9th Annual IBA World Life Sciences Conference
31 May - 2 Jun 2023
Session information
Plenary session three - M&A panel on current trends in the HCLS industry
Thursday 1 June (1600 - 1700)
Description
The M&A panel will focus on recent worldwide M&A activity in the life science sector, and market dynamics that are impacting levels of M&A activity. The panel will consider various types of deals as well as alternatives to M&A such as licensing and collaboration deals between biotechs and big pharma. Considerations such as the state of capital markets and regulatory developments will also be reviewed.
Session / Workshop Chair(s)
| Bill Whelan | Mintz, Boston, Massachusetts, USA |
Speakers
| Lorenza Ferrari-Hofer | Schellenberg Wittmer, Zürich, Switzerland |
| Pamela F Forrest | Covington & Burling LLP, Washington, District of Columbia, USA |
| Murphy Gallagher | SVB Securities, Washington, District of Columbia, USA |
| Jabali Wells | Blackpoll Capital Partners LLC, Washington, District of Columbia, USA |
| Feng Zhou | JunHe LLP, Shanghai, China; Membership Officer, Healthcare and Life Sciences Law Committee |